All treatments
Treatment
Remibrutinib Dose B clinical trials
2 indexed studies · 0 currently recruiting
- Active not recruitingPHASE3
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa
This study is testing a new medicine, remibrutinib, for people aged 12 and over with moderate to severe hidradenitis suppurativa (HS). Researchers want to see if it's safe and effective compared to a dummy pill.
For: Hidradenitis SuppurativaUnited States · Argentina · Austria - Active not recruitingPHASE3
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
This study is testing a new medicine called remibrutinib for people aged 12 and older with moderate to severe hidradenitis suppurativa (HS). It aims to see how well it works and if it's safe compared to a dummy pill.
For: Hidradenitis SuppurativaUnited States · Argentina · Australia